Medicare Enrolled
Dr. Jagdish Mishra, MD
Nuclear Medicine · Batavia, NY
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mishra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mishra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mishra
Dr. Jagdish Mishra is a nuclear medicine specialist in Batavia, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mishra performed 2,581 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mishra received a total of $11,076 from 38 pharmaceutical and/or device companies across 567 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mishra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 20% volume in NY
$11,076 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,581
Medicare services
Top 20% in NY for nuclear medicine
Not available
Unique patients (not deduplicated)
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
700 | $58 | $115 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
659 | $9 | $26 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
592 | $134 | $589 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
203 | $6 | $16 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
47 | $167 | $600 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
44 | $48 | $168 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
43 | $16 | $111 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
41 | $35 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $93 | $148 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
39 | $60 | $99 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
38 | $44 | $250 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
33 | $91 | $274 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $123 | $275 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
25 | $75 | $155 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
21 | $52 | $100 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
18 | $333 | $750 |
| 30-day continuous ECG with symptom monitoring This procedure involves continuous electrocardiogram monitoring for up to 30 days, including symptom tracking and a professional review and report of the results. |
12 | $135 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
26.9% high complexity
8.6% medium
64.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,076
Total received (2018-2024)
Avg $1,582/year across 7 years
Top 9% in NY for nuclear medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
567
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,624
2023
$1,703
2022
$1,883
2021
$1,460
2020
$1,156
2019
$1,625
2018
$1,623
Payments by company (2024)
BIOTRONIK INC.
$279
Novartis Pharmaceuticals Corporation
$201
Amgen Inc.
$187
Lexicon Pharmaceuticals, Inc.
$182
Janssen Pharmaceuticals, Inc
$127
Medtronic, Inc.
$110
Boehringer Ingelheim Pharmaceuticals, Inc.
$109
ABIOMED
$90
Novo Nordisk Inc
$84
Merck Sharp & Dohme LLC
$60
AstraZeneca Pharmaceuticals LP
$57
Edwards Lifesciences Corporation
$32
ATRICURE, INC.
$25
iRhythm Technologies, Inc.
$25
CVRx, Inc.
$22
SCPHARMACEUTICALS INC.
$19
PFIZER INC.
$15
Top 3 companies account for 41.1% of 2024 payments
All-time payments by company (2018-2024) ›
BIOTRONIK INC.
$2,159
Novartis Pharmaceuticals Corporation
$1,282
Astellas Pharma US Inc
$1,104
Janssen Pharmaceuticals, Inc
$937
AstraZeneca Pharmaceuticals LP
$925
Amgen Inc.
$638
PFIZER INC.
$552
Merck Sharp & Dohme LLC
$454
Boehringer Ingelheim Pharmaceuticals, Inc.
$417
SANOFI-AVENTIS U.S. LLC
$285
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$236
Edwards Lifesciences Corporation
$205
Lexicon Pharmaceuticals, Inc.
$201
Medtronic Vascular, Inc.
$174
Gilead Sciences, Inc.
$149
Kowa Pharmaceuticals America, Inc.
$145
Novo Nordisk Inc
$139
Impulse Dynamics (USA) Inc.
$132
Medtronic, Inc.
$127
SCPHARMACEUTICALS INC.
$117
Merck Sharp & Dohme Corporation
$97
ABIOMED
$90
Abbott Laboratories
$52
iRhythm Technologies, Inc.
$48
Esperion Therapeutics, Inc.
$44
Amarin Pharma Inc.
$41
Bardy Diagnostics, Inc.
$40
BOSTON SCIENTIFIC CORPORATION
$40
Baxter Healthcare
$39
Boston Scientific Corporation
$33
Regeneron Healthcare Solutions, Inc.
$27
ATRICURE, INC.
$25
E.R. Squibb & Sons, L.L.C.
$24
Preventice Services, LLC
$23
CVRx, Inc.
$22
Kiniksa Pharmaceuticals, Ltd.
$19
Alnylam Pharmaceuticals Inc.
$18
Daiichi Sankyo Inc.
$16
Top 3 companies account for 41.0% of all-time payments
Associated products mentioned in payments ›
AMVIA EDGE · AZURE XT DR MRI SURESCAN · Acticor · Acticor 7 VR-T DX · Arcalyst · Azure · BG Mini Plus · BIOMONITOR · BRILINTA · Barostim Neo System · BioMonitor · BioMonitor 2 · CHANTIX · CONFIRM RX · Carnation Ambulatory Monitor · Claria MRI · Corlanor · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edora · Edora 8 DR-T · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Evera · FARXIGA · FUROSCIX · Hillrom - Carnation Ambulatory Monitor · INJECTAFER · Impella · Inpefa · JARDIANCE · LEQVIO · LEXISCAN · Lexiscan · LifeVest · Livalo · MICRA · MULTAQ · MitraClip System · NEXLETOL · ONPATTRO · OPTIMIZER · Ozempic · PRADAXA · PRALUENT · QUADRA ASSURA · RESONATE · Renamic Neo · Repatha · Reveal LINQ · Rivacor · Rivacor 7 DR-T · Rybelsus · SAPIEN 3 Ultra RESILIA · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Nuclear medicines in nearby ZIP areas
3
County median income
$72,055
Nearest hospital to ZIP centroid (approximate)
UNITED MEMORIAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mishra is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 20% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mishra experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Mishra performed 700 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mishra receive payments from pharmaceutical companies?
Yes. Dr. Mishra received a total of $11,076 from 38 companies across 567 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mishra's costs compare to other nuclear medicines in Batavia?
Dr. Mishra's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mishra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Nuclear Medicines in Batavia
Browse nuclear medicines in Batavia ranked by procedure volume and transparency data.
Highest volume
Top Nuclear Medicines in NY
Nuclear medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nuclear Medicines in NY
Which NY nuclear medicines receive the most from drug and device companies.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology